A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours

被引:0
作者
D S Boss
H Glen
J H Beijnen
M Keesen
R Morrison
B Tait
W Copalu
A Mazur
J Wanders
J P O'Brien
J H M Schellens
T R J Evans
机构
[1] The Netherlands Cancer Institute,Division of Medical Oncology, Department of Clinical Pharmacology
[2] Plesmanlaan 121,Department of Pharmacy
[3] Beatson West of Scotland Cancer Centre,Department of Biomedical Analysis
[4] Slotervaart Hospital,undefined
[5] Utrecht University,undefined
[6] Eisai Europe Limited,undefined
[7] European Knowledge Centre,undefined
[8] Eisai Inc.,undefined
[9] Woodcliff Lake,undefined
[10] NJ,undefined
[11] USA,undefined
[12] Institute of Cancer Sciences,undefined
[13] University of Glasgow,undefined
来源
British Journal of Cancer | 2012年 / 106卷
关键词
dose escalation; E7080; pharmacokinetics; phase I; receptor tyrosine kinase inhibitor; solid tumours;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1598 / 1604
页数:6
相关论文
共 282 条
[1]  
Basu B(2009)Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies Expert Rev Anticancer Ther 9 1583-1598
[2]  
Biswas S(2006)Somatic activation of KIT in distinct subtypes of melanoma J Clin Oncol 24 4340-4346
[3]  
Wrigley J(2005)Angiogenesis: update 2005 J Thromb Haemost 3 1835-1842
[4]  
Sirohi B(2007)Sorafenib in advanced clear-cell renal-cell carcinoma N Engl J Med 356 125-134
[5]  
Corrie P(2006)The clinical toxicity profile of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) targeting angiogenesis inhibitors; a review Eur J Cancer 42 3127-3139
[6]  
Curtin JA(2006)Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer J Clin Oncol 24 25-35
[7]  
Busam K(2003)The biology of VEGF and its receptors Nat Med 9 669-676
[8]  
Pinkel D(1972)Anti-angiogenesis: new concept for therapy of solid tumors Ann Surg 175 409-416
[9]  
Bastian BC(2007)A phase I dose finding study of E7080 in patients (pts) with advanced malignancies J Clin Oncol 25 617s-2909
[10]  
Dvorak HF(2008)A phase I study of E7080 in patients (pts) with advanced malignancies J Clin Oncol 26 159s-904